• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[改良版前列腺腺癌Gleason分级系统在常规泌尿外科诊断中的价值]

[The value of the modified Gleason grading system of prostate adenocarcinoma in routine urological diagnostics].

作者信息

Helpap B, Egevad L

机构信息

Konsultationsdienst für Uropathologie, Institut für Pathologie, Singen.

出版信息

Urologe A. 2007 Jan;46(1):59-62. doi: 10.1007/s00120-006-1238-9.

DOI:10.1007/s00120-006-1238-9
PMID:17111167
Abstract

In several consensus conferences of the International Society of Urological Pathology (ISUP), the Gleason grading system of prostatic carcinomas was modified and adapted to the routine histological diagnostics of specimens of core needle biopsies and radical prostatectomies. The main results are the documentation of all histological patterns (primary, secondary, tertiary) and a shifting of the maximal Gleason score of biopsies from 6 to 7a (3+4) and of radical prostatectomies from 6 and 7 to 7a and 7b (4+3). Score 2 to 4 carcinomas do not exist in the peripheral prostate. pT2 prostatic carcinomas with good prognosis have a maximal score of 7a; pT3 carcinomas with poor prognosis have a most frequent score of 7b. The agreement of the Gleason scores of core needle biopsies and radical prostatectomy specimens is more than 80%. Inter- and intraobserver reproducibility is better than after the conventional Gleason grading. The prognostic value of scores 6 and 7a may be similar. The border between low- and high-grade prostatic carcinoma may be probably Gleason score 7a and 7b. The prognostic value of score 6 should be changed to score 7a in the different therapeutic options for prostatic carcinomas.

摘要

在国际泌尿病理学会(ISUP)的几次共识会议上,前列腺癌的Gleason分级系统进行了修改,以适应经皮穿刺活检和根治性前列腺切除术标本的常规组织学诊断。主要结果是记录了所有组织学模式(主要、次要、三级),活检的最大Gleason评分从6改为7a(3+4),根治性前列腺切除术的最大Gleason评分从6和7改为7a和7b(4+3)。外周前列腺不存在2至4分的癌。预后良好的pT2前列腺癌的最大评分为7a;预后不良的pT3癌最常见的评分为7b。经皮穿刺活检和根治性前列腺切除术标本的Gleason评分一致性超过80%。观察者间和观察者内的可重复性优于传统Gleason分级。6分和7a分的预后价值可能相似。低级别和高级别前列腺癌之间的界限可能是Gleason评分7a和7b。在前列腺癌的不同治疗选择中,6分的预后价值应改为7a分。

相似文献

1
[The value of the modified Gleason grading system of prostate adenocarcinoma in routine urological diagnostics].[改良版前列腺腺癌Gleason分级系统在常规泌尿外科诊断中的价值]
Urologe A. 2007 Jan;46(1):59-62. doi: 10.1007/s00120-006-1238-9.
2
Modified Gleason grading. An updated review.改良 Gleason 分级:最新综述
Histol Histopathol. 2009 May;24(5):661-6. doi: 10.14670/HH-24.661.
3
The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.2005年国际泌尿病理学会共识会议对前列腺穿刺活检中前列腺癌Gleason分级标准的影响。
J Urol. 2008 Aug;180(2):548-52; discussion 552-3. doi: 10.1016/j.juro.2008.04.018. Epub 2008 Jun 11.
4
Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue.前列腺针芯活检组织中高 Gleason 评分 8 至 10 分腺癌的常见和不常见组织学形态。
Am J Surg Pathol. 2012 Jun;36(6):900-7. doi: 10.1097/PAS.0b013e3182495dee.
5
Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.当代前列腺癌的Gleason分级:结合对实施2014年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议实际问题的讨论进行更新
Am J Surg Pathol. 2017 Apr;41(4):e1-e7. doi: 10.1097/PAS.0000000000000820.
6
Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.在格里森(Gleason)和国际泌尿病理学会(ISUP)前列腺癌分级中存在争议的问题:国际实施的建议。
Pathology. 2019 Aug;51(5):463-473. doi: 10.1016/j.pathol.2019.05.001. Epub 2019 Jul 3.
7
Implications of the International Society of Urological Pathology modified Gleason grading system.国际泌尿病理学会改良 Gleason 分级系统的意义。
Arch Pathol Lab Med. 2012 Apr;136(4):426-34. doi: 10.5858/arpa.2011-0495-RA.
8
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.SOCS3免疫组化表达似乎支持2005年和2014年国际泌尿病理学会(ISUP)改良的Gleason分级系统。
Prostate. 2017 May;77(6):597-603. doi: 10.1002/pros.23299. Epub 2017 Feb 1.
9
The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.改良Gleason分级在前列腺癌活检及根治性前列腺切除标本中的意义。
Virchows Arch. 2006 Dec;449(6):622-7. doi: 10.1007/s00428-006-0310-6. Epub 2006 Nov 8.
10
Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens.针吸活检与根治性前列腺切除术标本中前列腺癌的Gleason分级
Anal Quant Cytol Histol. 2005 Jun;27(3):125-33.

引用本文的文献

1
The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy.继发性循环前列腺肿瘤细胞的存在决定了仅接受体外放疗的低危和中危前列腺癌患者发生生化复发的风险。
Ecancermedicalscience. 2018 Jun 20;12:844. doi: 10.3332/ecancer.2018.844. eCollection 2018.
2
[Prostate gland - what would urologists like to know from radiologists?].[前列腺——泌尿科医生希望从放射科医生那里了解什么?]
Radiologe. 2017 Aug;57(8):608-614. doi: 10.1007/s00117-017-0273-4.
3
[Patients with prostate cancer after radical prostatectomy: Stage migration and changes in tumor characteristics from 1998-2012].

本文引用的文献

1
The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.改良Gleason分级在前列腺癌活检及根治性前列腺切除标本中的意义。
Virchows Arch. 2006 Dec;449(6):622-7. doi: 10.1007/s00428-006-0310-6. Epub 2006 Nov 8.
2
A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies.一项基于英国的前列腺活检Gleason分级观察者间和观察者内可重复性的调查。
Histopathology. 2006 May;48(6):644-54. doi: 10.1111/j.1365-2559.2006.02393.x.
3
Current practice of Gleason grading of prostate carcinoma.
根治性前列腺切除术后前列腺癌患者:1998年至2012年的分期迁移及肿瘤特征变化
Urologe A. 2016 Feb;55(2):167-75. doi: 10.1007/s00120-015-3988-8.
4
[Documentation quality of histopathology reports of prostate needle biopsies: a snapshot].[前列腺穿刺活检组织病理学报告的文档质量:一个快照]
Urologe A. 2014 Nov;53(11):1644-50. doi: 10.1007/s00120-014-3584-3.
5
[Clinical insignificance of prostate cancer: are there morphological findings?].[前列腺癌的临床无意义:是否存在形态学发现?]
Urologe A. 2009 Feb;48(2):170-4. doi: 10.1007/s00120-008-1867-2.
前列腺癌Gleason分级的当前实践。
Virchows Arch. 2006 Feb;448(2):111-8. doi: 10.1007/s00428-005-0102-4. Epub 2005 Nov 23.
4
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.2005年国际泌尿病理学会(ISUP)前列腺癌Gleason分级共识会议。
Am J Surg Pathol. 2005 Sep;29(9):1228-42. doi: 10.1097/01.pas.0000173646.99337.b1.
5
Gleason grading and prognostic factors in carcinoma of the prostate.前列腺癌的 Gleason 分级及预后因素
Mod Pathol. 2004 Mar;17(3):292-306. doi: 10.1038/modpathol.3800054.
6
Interobserver reproducibility of percent Gleason grade 4/5 in total prostatectomy specimens.前列腺切除标本中Gleason 4/5级所占百分比的观察者间可重复性。
J Urol. 2002 Nov;168(5):2006-10. doi: 10.1016/S0022-5347(05)64283-8.
7
Fundamentals on the pathology of prostatic carcinoma after brachytherapy.
World J Urol. 2002 Sep;20(4):207-12. doi: 10.1007/s00345-002-0288-x. Epub 2002 Aug 15.
8
The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system.
Am J Surg Pathol. 2000 Apr;24(4):563-9. doi: 10.1097/00000478-200004000-00011.
9
Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made.穿刺活检显示 Gleason 评分 2 - 4 的前列腺腺癌:不应做出的诊断。
Am J Surg Pathol. 2000 Apr;24(4):477-8. doi: 10.1097/00000478-200004000-00001.
10
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.前列腺特异性抗原、临床分期和 Gleason 评分相结合预测局限性前列腺癌的病理分期。一项多机构更新研究。
JAMA. 1997 May 14;277(18):1445-51.